We are live on ! Find out more
CKPT

Checkpoint Therapeutics
CKPT

Delisted

CKPT was delisted on the 29th of May, 2025.

Back to rankings

62 hedge funds and large institutions have $30.7M invested in Checkpoint Therapeutics in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 29 increasing their positions, 8 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

263% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 8

113% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 8

17% more funds holding

Funds holding: 53 → 62 (+9)

0.14% less ownership

Funds ownership: 2.12% → 1.98% (-0.14%)

10% less capital invested

Capital invested by funds: $34M → $30.7M (-$3.37M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
62
Holders Change
+9
Holders Change %
+16.98%
% of All Funds
1.1%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
17
Increased
29
Reduced
8
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$1.24M
2
TI
tru Independence
Oregon
+$1.1M
3
Millennium Management
Millennium Management
New York
+$693K
4
BlackRock
BlackRock
New York
+$433K
5
Two Sigma Investments
Two Sigma Investments
New York
+$364K

Top Sellers

Rank Fund Capital Flow
1
CH
CVI Holdings
Delaware
-$5.02M
2
SM
Sabby Management
Florida
-$2.5M
3
Renaissance Technologies
Renaissance Technologies
New York
-$227K
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$214K
5
TRCT
Tower Research Capital (TRC)
New York
-$96.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
51
Susquehanna International Group
Pennsylvania
$27K +$25.4K +1,002 New
Osaic Holdings
52
Osaic Holdings
Arizona
$25K +$1.39K +55 +6%
Citigroup
53
Citigroup
New York
$25K +$18.1K +716 +330%
Bank of Montreal
54
Bank of Montreal
Ontario, Canada
$22K +$15.6K +616 +295%
TRCT
55
Tower Research Capital (TRC)
New York
$21K -$96.9K -3,831 -83%
SFS
56
Sowell Financial Services
Arkansas
$19K +$17.8K +702 New
PAM
57
Panagora Asset Management
Massachusetts
$14K -$7.82K -309 -37%
PNC Financial Services Group
58
PNC Financial Services Group
Pennsylvania
$11K – – –
AIP
59
Ameritas Investment Partners
Nebraska
$5K – – –
TI
60
tru Independence
Oregon
$1.15K +$1.1M +43,500 New
RFA
61
Reilly Financial Advisors
California
$1K – – –
AIG
62
American International Group
New York
$80 +$7.89K +312 +12%
SM
63
Sabby Management
Florida
– -$2.5M -93,124 Closed
Acadian Asset Management
64
Acadian Asset Management
Massachusetts
– -$214K -7,969 Closed
CSS
65
Cubist Systematic Strategies
Connecticut
– -$50K -1,855 Closed
Commonwealth Equity Services
66
Commonwealth Equity Services
Massachusetts
– -$42K -1,600 Closed
SO
67
STRS Ohio
Ohio
– -$16K -620 Closed
ASN
68
Advisory Services Network
Georgia
– -$7K -276 Closed
CCM
69
Chiron Capital Management
Florida
– -$5K -200 Closed
MAM
70
Meeder Asset Management
Ohio
– -$2K -92 Closed
1 2
3

CKPT Hedge Fund Activity: Q4 2020 in Review

62 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Checkpoint Therapeutics (CKPT) for Q4 2020, worth a combined $30.7M — down 9.9% from $34M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new CKPT positions and 8 closed out — a net gain of 9 holders — while 29 added to existing stakes and 8 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $1.24M. The largest seller was CVI Holdings, cutting an estimated $5.02M.

  • 62 institutional investors held Checkpoint Therapeutics (CKPT) as of Q4 2020, up from 53 in Q3 2020.
  • Funds reported $30.7M of Checkpoint Therapeutics stock for Q4 2020, down 9.9% quarter-over-quarter.
  • 17 funds opened new Checkpoint Therapeutics positions in Q4 2020 and 8 closed out, a net change of +9 holders.
  • The largest Checkpoint Therapeutics buyer in Q4 2020 was Morgan Stanley, an estimated $1.24M added.
  • The largest Checkpoint Therapeutics seller in Q4 2020 was CVI Holdings, an estimated $5.02M sold.

Based on aggregated 13F filings for Q4 2020.